Policy | June 06, 2025
NPPA fixes retail prices for 41 drug combinations
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Pivotal results from the Phase 3 Breakwater trial showed 51% risk reduction in death compared to standard-of-care treatment
Sun Pharma will invest up to $25 million in US-based Pharmazz Inc, raising its stake to 22.7%
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The launch follows the approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), U.K.
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
Such combined efficacy (achieving clinical cure and microbiologic cure) of Zaynich is highest ever among all the FDA-approved novel antibiotics developed in the last more than 10 years
Subscribe To Our Newsletter & Stay Updated
